Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. Gross Profit 2010–2025
Novavax Inc. annual/quarterly gross profit history and growth rate from 2020 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Novavax Inc. gross profit for the quarter ending March 31, 2026 was 108.8 M, a 83.32% decrease year-over-year.
- Novavax Inc. gross profit for the twelve months ending March 31, 2026 was 1.0 B, a 100.49% increase year-over-year.
- Novavax Inc. annual gross profit for 2025 was 1.1 B, a 119.10% increase from 2024.
- Novavax Inc. annual gross profit for 2024 was 479.4 M, a 25.08% decrease from 2023.
- Novavax Inc. annual gross profit for 2023 was 639.9 M, a 40.70% decrease from 2022.
- Novavax Inc. annual gross profit for 2022 was 1.1 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Novavax Inc. Gross Profit — FAQ
Novavax Inc. (NVAX) gross profit over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
What is Novavax Inc.'s gross profit?
Novavax Inc. (NVAX) reported gross profit of $1.05B for fiscal 2025.
Where can I see NVAX's gross profit history?
The chart and table above show Novavax Inc.'s gross profit by year and by quarter, including the growth rate.